|Anticipated publication date||June 2010|
|13 August 2008||
The review conducted in March 2008 has concluded that this guideline warrants a partial update.
The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to whom it will apply.
|22 September 2008||The draft scope is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations, by the deadline shown.|
|21 October 2008||Consultation on the draft of the guideline is complete, and the guideline is being modified in the light of comments received.|
|5 December 2008||Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review, and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline. Please see timescales for dates of consultation with stakeholders.|
|8 December 2008||The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table. The Guideline Development Group (GDG) oversees the development process.|
|1 April 2009||Responsibility for the development of this guideline has transferred to the National Clinical Guidelines Centre. Key contacts and timelines remain unchanged.|
|6 April 2010||The final draft of the full guideline is available for its pre-publication check. If you wish to report a factual error you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.|